美國Genomic Solutions www.genomicsolutions.com
Genomic Solutions依托哈佛大學的生命科學技術(shù)，成立于1901年，是納斯達克上市公司，后又收購了著名的芯片點樣儀生產(chǎn)廠家Cartesion和GeneMachines，成為基因組、蛋白質(zhì)組學領(lǐng)域的著名儀器生產(chǎn)商。從基因組學的核酸的分裝、點樣、掃描成像、數(shù)據(jù)分析到蛋白組學的二維電泳、自動切膠、蛋白酶解、點樣、數(shù)據(jù)分析，都提供完整的自動化儀器。公司產(chǎn)品面向60多個國家和地區(qū)，近五年的公司年增長率達到38%，成為國際知名的生命科學儀器生產(chǎn)商。

Genomic Solutions® designs, develops, and manufactures genomic and proteomic instrumentation, software, consumables and services. We are the only company supplying tools and expertise for genomics, proteomics, and low-volume liquid handling.
Our instruments can be purchased individually or as part of fully integrated systems tailored to genomic, proteomic and drug discovery research requirements. Our customers use our integrated, automated systems to facilitate more rapid and less expensive drug discovery. Genomic Solutions® products provide high quality research data and fast turnaround time. Now, as part of the Harvard Bioscience family of companies, Genomic Solutions® and Union Biometrica are proud to offer complete solutions to life science research needs.
Company History
Genomic Solutions® was formed in 1997 to address the emerging research needs for innovative, first to market automated genomic and proteomic instruments. 
A series of strategic acquisitions combined with internal R&D, resulted in the release of the comprehensive GeneTAC TM Biochip and Investigator TM Proteomic systems in 1999 and 2000 respectively. 
Genomic Solutions® became a publicly held company with a highly successful initial public offering (Nasdaq NM: GNSL), May 2000. 
Through a series of strategic alliances, product development initiatives and timely organizational refinements, the company bolstered its market position as a single-source supplier of tools and services for both genomic and proteomic researchers. 
During the fourth quarter of 2001, Genomic Solutions® acquired Cartesian Technologies, Inc., further strengthening product choices available to customers and additionally moving the company into the emerging high-throughput screening market. 
During the fourth quarter of 2002, Genomic Solutions® was acquired by Harvard Bioscience (Nasdaq: HBIO) and became a wholly owned subsidiary of HBIO. 
During the first quarter of 2003, Genomic Solutions® acquired GeneMachines (San Carlos, CA), further enhancing market strength in microarray technology. 
During the third quarter of 2003, Genomic Solutions® acquired BioRobotics (UK), solidifying market strength and position in microarray technology.